Search
for

    Sort by

    Research 811–840 of 876

    1. Comparative evaluation of eyebrow rejuvenation using hibiscus oil 5% (w/v) with and without Gua-sha: A split face randomized control Trial National Journal of Maxillofacial Surgery · 2026
    2. Pathophysiology of Androgenetic Alopecia and Implications for Treatment: An Overview of Current Literature Journal of Biosciences and Medicines · 2026
    3. Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course Saudi Journal of Internal Medicine · 2026
    4. Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib Dermatologic Therapy · 2026
    5. Expert consensus on systemic treatment activation and grading evaluation for alopecia areata Chinese Medical Journal · 2025
    6. Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older Actas Dermo-Sifiliográficas · 2025
    7. Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype 2025
    8. A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes Journal of Clinical Medicine · 2025
    9. British Association of Dermatologists living guideline for managing people with alopecia areata 2025 British Journal of Dermatology · 2025
    10. Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience Journal of Cutaneous Medicine and Surgery · 2025
    11. Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss International Journal of Molecular Sciences · 2025
    12. Real-world evidence in alopecia areata treatment: A narrative review Dermatologica Sinica · 2025
    13. Quality of life in patients with scarring and non‐scarring alopecia: An exploratory cross‐sectional study JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2025
    14. A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making Value in Health · 2025
    15. Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia. PubMed · 2025
    16. Comorbidities in primary cicatricial alopecia: a systematic review and meta-analysis Frontiers in Immunology · 2025
    17. Frontal Fibrosing Alopecia and the Role of Cosmeceuticals in Its Pathogenesis Cosmetics · 2025
    18. Cancer-Related Alopecia Risk and Treatment Current Treatment Options in Oncology · 2025
    19. COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists JEADV Clinical Practice · 2025
    20. Enhancing hair regrowth in Alopecia areata: the power duo of CO2 fractional laser and Bimatoprost Archives of Dermatological Research · 2025
    21. Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients Indian Journal of Dermatology Venereology and Leprology · 2025
    22. Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration Journal of Clinical Medicine · 2025
    23. Advancements in non-laser energy-based devices in trichology: A comprehensive review Journal of Cutaneous and Aesthetic Surgery · 2025
    24. Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment The Journal of Dermatology · 2025
    25. Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata Dermatologic Therapy · 2025
    26. Latanoprost 2025
    27. Medical Remedies for Alopecia Research Journal of Topical and Cosmetic Sciences · 2024
    28. Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia Life · 2024
    29. Identification and characterization of alopecia areata subgroups regarding quality of life impairment based on demographic, clinical, psychological, and social factors Psychology Health & Medicine · 2024
    30. Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention Current Oncology · 2024